Ultra-Treatment-Resistant Schizophrenia and Clozapine Augmentation

被引：0
|
作者：
Tirupati, Srinivasan [1 ,2 ]
机构：
[1] Psychiat Rehabil Serv, Hunter New England Mental Hlth, Morisset, Australia
[2] Univ Newcastle, Fac Hlth, Sch Med & Publ Hlth, Callaghan, Australia
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2023年 / 43卷 / 02期
关键词：
PRACTICE GUIDELINES; MANAGEMENT;
D O I：
10.1097/JCP.0000000000001652
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：183 / 184
页数：2
相关论文
共 50 条
  • [1] High-Dose Fluvoxamine Augmentation to Clozapine in Treatment-Resistant Psychosis
    Leising, Julie
    Barr, Alasdair M.
    Procyshyn, Ric M.
    Ainsworth, Nicholas J.
    White, Randall F.
    Honer, William
    Vila-Rodriguez, Fidel
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2021, 41 (02) : 186 - 190
  • [2] Clozapine dosing patterns and clinical outcomes in patients with treatment resistant schizophrenia
    Chan, Sherry Kit Wa
    Suen, Yi Nam
    Yan, Wai Ching
    Lam, Chun
    Chui, Eileena
    Hui, Christy Lai Ming
    Chang, Wing Chung
    Lee, Edwin Ho Ming
    Chen, Eric Yu Hai
    Honer, William G.
    Takeuchi, Hiroyoshi
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2023, 75 : 67 - 79
  • [3] G-CSF mediated neutrophil augmentation in a unique case of comorbid idiopathic Parkinson's disease and treatment-resistant schizophrenia on clozapine
    Morrow, Olivia
    Gibson, Lucy
    Bhamra, Manraj
    David, Anthony S.
    Posporelis, Sotirios
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2020, 10
  • [4] Polypharmacy to Clozapine Monotherapy in Treatment-Resistant Schizophrenia: A Case Report and Review of the Literature
    Bokhari, Syed Ali
    Lutfi, Lubna
    Elnoor, Muhanad
    Mujahid, Beenish
    Osman, Abdelaziz
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [5] An international research agenda for clozapine-resistant schizophrenia
    Luykx, Jurien J.
    Gonzalez -Diaz, Jairo M.
    Guu, Ta-Wei
    van der Horst, Marte Z.
    van Dellen, Edwin
    Boks, Marco P.
    Guloksuz, Sinan
    Delisi, Lynn E.
    Sommer, Iris E.
    Cummins, Russel
    Shiers, David
    Lee, Jimmy
    Every-Palmer, Susanna
    Mhalla, Ahmed
    Chadly, Zohra
    Chan, Sherry K. W.
    Cotes, Robert
    Takahashi, Shun
    Benros, Michael E.
    Wagner, Elias
    Correll, Christoph U.
    Hasan, Alkomiet
    Siskind, Dan
    Endres, Dominique
    MacCabet, James
    Tiihonen, Jari
    LANCET PSYCHIATRY, 2023, 10 (08): : 644 - 652
  • [6] Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial
    Barnes, Thomas R. E.
    Leeson, Verity
    Paton, Carol
    Marston, Louise
    Osborn, David P.
    Kumar, Raj
    Keown, Patrick
    Zafar, Rameez
    Iqbal, Khalid
    Singh, Vineet
    Fridrich, Pavel
    Fitzgerald, Zachary
    Bagalkote, Hemant
    Haddad, Peter M.
    Husni, Mariwan
    Amos, Tim
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2018, 8 (07) : 185 - 197
  • [7] Add-on of aripiprazole improves outcome in clozapine-resistant schizophrenia
    De Risio, Alessandro
    Pancheri, Angelo
    Simonetti, Giovanna
    Giannarelli, Diana
    Stefanutto, Luciana
    Gentile, Bruno
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (04): : 1112 - 1116
  • [8] Effectiveness of Clozapine on Employment Outcomes in Treatment-Resistant Schizophrenia: A Retrospective Bidirectional Mirror-Image Study
    Matsuzaki, Haruna
    Hatano, Masakazu
    Iwata, Miko
    Saito, Takeo
    Yamada, Shigeki
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2023, 19 : 615 - 622
  • [9] A systematic review and meta-analysis of the effect of clozapine on cognitive functions in patients with treatment-resistant schizophrenia
    Cheuk, Natalie Kwok Wing
    Tse, Wing
    Tsui, Harry Kam Hung
    Ma, Chak Fai
    Chun, Johnny Siu Wah
    Chung, Albert Kar Kin
    Chan, Sherry Kit Wa
    SCHIZOPHRENIA RESEARCH, 2024, 268 : 205 - 222
  • [10] Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine
    De Berardis, Domenico
    Rapini, Gabriella
    Olivieri, Luigi
    Di Nicola, Domenico
    Tomasetti, Carmine
    Valchera, Alessandro
    Fornaro, Michele
    Di Fabio, Fabio
    Perna, Giampaolo
    Di Nicola, Marco
    Serafini, Gianluca
    Carano, Alessandro
    Pompili, Maurizio
    Vellante, Federica
    Orsolini, Laura
    Martinotti, Giovanni
    Di Giannantonio, Massimo
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2018, 9 (05) : 237 - 256
12345